Cargando…

A model framework for projecting the prevalence and impact of Long-COVID in the UK

The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 disease in the UK population, including symptoms of ‘long-COVID’. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long-COVID. The prevalence of sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Chris, Luteijn, Michiel, Letton, William, Robertson, Josephine, McDonald, Stuart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639065/
https://www.ncbi.nlm.nih.gov/pubmed/34855874
http://dx.doi.org/10.1371/journal.pone.0260843
_version_ 1784609075172999168
author Martin, Chris
Luteijn, Michiel
Letton, William
Robertson, Josephine
McDonald, Stuart
author_facet Martin, Chris
Luteijn, Michiel
Letton, William
Robertson, Josephine
McDonald, Stuart
author_sort Martin, Chris
collection PubMed
description The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 disease in the UK population, including symptoms of ‘long-COVID’. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long-COVID. The prevalence of symptomatic COVID-19, encompassing acute symptoms and long-COVID symptoms, was modelled using a decay function. Permanent injury as a result of COVID-19 infection, was modelled as a fixed prevalence. Both parts were combined to calculate QALY loss due to COVID-19 symptoms. Assuming a 60% final attack rate for SARS-CoV-2 infection in the population, we modelled 299,730 QALYs lost within 1 year of infection (90% due to symptomatic COVID-19 and 10% permanent injury) and 557,764 QALYs lost within 10 years of infection (49% due to symptomatic COVID-19 and 51% due to permanent injury). The UK Government willingness-to-pay to avoid these QALY losses would be £17.9 billion and £32.2 billion, respectively. Additionally, 90,143 people were subject to permanent injury from COVID-19 (0.14% of the population). Given the ongoing development in information in this area, we present a model framework for calculating the health economic impacts of symptoms following SARS-CoV-2 infection. This model framework can aid in quantifying the adverse health impact of COVID-19, long-COVID and permanent injury following COVID-19 in society and assist the proactive management of risk posed to health. Further research is needed using standardised measures of patient reported outcomes relevant to long-COVID and applied at a population level.
format Online
Article
Text
id pubmed-8639065
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86390652021-12-03 A model framework for projecting the prevalence and impact of Long-COVID in the UK Martin, Chris Luteijn, Michiel Letton, William Robertson, Josephine McDonald, Stuart PLoS One Research Article The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 disease in the UK population, including symptoms of ‘long-COVID’. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long-COVID. The prevalence of symptomatic COVID-19, encompassing acute symptoms and long-COVID symptoms, was modelled using a decay function. Permanent injury as a result of COVID-19 infection, was modelled as a fixed prevalence. Both parts were combined to calculate QALY loss due to COVID-19 symptoms. Assuming a 60% final attack rate for SARS-CoV-2 infection in the population, we modelled 299,730 QALYs lost within 1 year of infection (90% due to symptomatic COVID-19 and 10% permanent injury) and 557,764 QALYs lost within 10 years of infection (49% due to symptomatic COVID-19 and 51% due to permanent injury). The UK Government willingness-to-pay to avoid these QALY losses would be £17.9 billion and £32.2 billion, respectively. Additionally, 90,143 people were subject to permanent injury from COVID-19 (0.14% of the population). Given the ongoing development in information in this area, we present a model framework for calculating the health economic impacts of symptoms following SARS-CoV-2 infection. This model framework can aid in quantifying the adverse health impact of COVID-19, long-COVID and permanent injury following COVID-19 in society and assist the proactive management of risk posed to health. Further research is needed using standardised measures of patient reported outcomes relevant to long-COVID and applied at a population level. Public Library of Science 2021-12-02 /pmc/articles/PMC8639065/ /pubmed/34855874 http://dx.doi.org/10.1371/journal.pone.0260843 Text en © 2021 Martin et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Martin, Chris
Luteijn, Michiel
Letton, William
Robertson, Josephine
McDonald, Stuart
A model framework for projecting the prevalence and impact of Long-COVID in the UK
title A model framework for projecting the prevalence and impact of Long-COVID in the UK
title_full A model framework for projecting the prevalence and impact of Long-COVID in the UK
title_fullStr A model framework for projecting the prevalence and impact of Long-COVID in the UK
title_full_unstemmed A model framework for projecting the prevalence and impact of Long-COVID in the UK
title_short A model framework for projecting the prevalence and impact of Long-COVID in the UK
title_sort model framework for projecting the prevalence and impact of long-covid in the uk
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639065/
https://www.ncbi.nlm.nih.gov/pubmed/34855874
http://dx.doi.org/10.1371/journal.pone.0260843
work_keys_str_mv AT martinchris amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT luteijnmichiel amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT lettonwilliam amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT robertsonjosephine amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT mcdonaldstuart amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT martinchris modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT luteijnmichiel modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT lettonwilliam modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT robertsonjosephine modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk
AT mcdonaldstuart modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk